Compass Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Compass Capital Management's PFE Position: Q3 2019 in Review
Compass Capital Management sold out of Pfizer (PFE) in Q3 2019, closing a stake of 5,243 shares — an estimated $215K sold.
Compass Capital Management first reported a position in PFE in Q3 2013 and held it in 19 quarters. The position peaked at $940K in Q1 2014. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.
- Compass Capital Management reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
- Compass Capital Management sold 5,243 Pfizer shares in Q3 2019, an estimated $215K.
- Compass Capital Management first reported a position in Pfizer in Q3 2013 and held it in 19 quarters.
- Compass Capital Management's Pfizer position peaked at $940K in Q1 2014.
- 2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.
Based on Compass Capital Management's 13F filing for Q3 2019, filed 22 Oct 2019.